Letarte M[au] - Search Results

Year	Number of Results
1978	3
1979	1
1980	4
1981	2
1982	5
1983	1
1984	6
1985	6
1986	8
1987	6
1988	8
1989	4
1990	4
1991	8
1992	6
1993	5
1994	4
1995	9
1996	3
1997	3
1998	1
1999	5
2000	7
2001	3
2002	2
2003	7
2004	3
2005	11
2006	7
2007	2
2008	1
2009	6
2010	3
2011	2
2012	3
2013	6
2014	13
2015	4
2017	2
2018	2
2019	1
2020	1
2022	0

1

Immunology Education Without Borders.

Kabelitz D, Letarte M, Gray CM. Kabelitz D, et al. Among authors: letarte m. Front Immunol. 2019 Aug 28;10:2012. doi: 10.3389/fimmu.2019.02012. eCollection 2019. Front Immunol. 2019. PMID: 31555265 Free PMC article. Review.

2

Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia.

Bernabeu C, Bayrak-Toydemir P, McDonald J, Letarte M. Bernabeu C, et al. Among authors: letarte m. J Clin Med. 2020 Nov 5;9(11):3571. doi: 10.3390/jcm9113571. J Clin Med. 2020. PMID: 33167572 Free PMC article. Review.

3

Endoglin: a critical mediator of cardiovascular health.

Kapur NK, Morine KJ, Letarte M. Kapur NK, et al. Among authors: letarte m. Vasc Health Risk Manag. 2013;9:195-206. doi: 10.2147/VHRM.S29144. Epub 2013 May 6. Vasc Health Risk Manag. 2013. PMID: 23662065 Free PMC article. Review.

4

Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Ardelean DS, Letarte M. Ardelean DS, et al. Among authors: letarte m. Front Genet. 2015 Feb 11;6:35. doi: 10.3389/fgene.2015.00035. eCollection 2015. Front Genet. 2015. PMID: 25717337 Free PMC article. Review.

5

Review: the enigmatic role of endoglin in the placenta.

Gregory AL, Xu G, Sotov V, Letarte M. Gregory AL, et al. Among authors: letarte m. Placenta. 2014 Feb;35 Suppl:S93-9. doi: 10.1016/j.placenta.2013.10.020. Epub 2013 Nov 8. Placenta. 2014. PMID: 24252708 Review.

6

Common components of evidence-based parenting programs for preventing maltreatment of school-age children.

Temcheff CE, Letarte MJ, Boutin S, Marcil K. Temcheff CE, et al. Among authors: letarte mj. Child Abuse Negl. 2018 Jun;80:226-237. doi: 10.1016/j.chiabu.2018.02.004. Epub 2018 Apr 7. Child Abuse Negl. 2018. PMID: 29631254 Review.

7

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Abdalla SA, Letarte M. Abdalla SA, et al. Among authors: letarte m. J Med Genet. 2006 Feb;43(2):97-110. doi: 10.1136/jmg.2005.030833. Epub 2005 May 6. J Med Genet. 2006. PMID: 15879500 Free PMC article. Review.

8

Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.

Bourdeau A, Faughnan ME, Letarte M. Bourdeau A, et al. Among authors: letarte m. Trends Cardiovasc Med. 2000 Oct;10(7):279-85. doi: 10.1016/s1050-1738(01)00062-7. Trends Cardiovasc Med. 2000. PMID: 11343967 Review.

9

Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Shovlin CL, Letarte M. Shovlin CL, et al. Among authors: letarte m. Thorax. 1999 Aug;54(8):714-29. doi: 10.1136/thx.54.8.714. Thorax. 1999. PMID: 10413726 Free PMC article. Review. No abstract available.

10

Increased endothelial cell permeability in endoglin-deficient cells.

Jerkic M, Letarte M. Jerkic M, et al. Among authors: letarte m. FASEB J. 2015 Sep;29(9):3678-88. doi: 10.1096/fj.14-269258. Epub 2015 May 13. FASEB J. 2015. PMID: 25972355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results